Author:
Poullenot Florian,Laharie David
Publisher
Springer Berlin Heidelberg
Reference63 articles.
1. Ford AC, Kane SV, Khan KJ, Achkar J-P, Talley NJ, Marshall JK, et al. Efficacy of 5-aminosalicylates in Crohn’s disease: systematic review and meta-analysis. Am J Gastroenterol. 2011;106(4):617–29.
2. Dignass A, Van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management. J Crohn's Colitis. 2010;4(1):28–62.
3. Gordon M, Naidoo K, Thomas AG, Akobeng AK. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn’s disease. Cochrane Database Syst Rev Online. 2011;1, CD008414.
4. Summers RW, Switz DM, Sessions Jr JT, Becktel JM, Best WR, Kern Jr F, et al. National cooperative Crohn’s disease study: results of drug treatment. Gastroenterology. 1979;77(4 Pt 2):847–69.
5. Faubion Jr WA, Loftus Jr EV, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121(2):255–60.